Skip to main content
SpringerLink
Log in

Bone marrow purging using monoclonal antibodies

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McGlave PB, Ramsay NKC, Kersey JH: Allogeneic and autologous bone marrow transplantation.In Recent Advances in Haematology—4, AV Hoffbrand (ed.) London, Churchill Livingstone, 1985, pp 171–197

    Google Scholar 

  2. Ramsay NKC: Bone marrow transplantation in pediatric oncology.In Principles and Practice of Pediatric Oncology, PA Pizzo, DG Poplack (eds). 1988 (in press)

  3. Vallera DA, Ash RC, Zanjani ED,et al. Anti-T-cell reagents for human bone marrow transplantation: Ricin linked to three monoclonal antibodies. Science 222:512–515, 1983

    Google Scholar 

  4. Filipovich AH, Vallera DA, Youle RJ,et al. Graft-versushost disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. Transplantation 44(1):62–69, 1987

    Google Scholar 

  5. Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA: Use of multiple T-cell directed intact ricin immunotoxins for autologous bone marrow transplantation. Blood 66(3):627–635, 1985

    Google Scholar 

  6. Vallera DA, Youle RJ, Neville DM Jr, Kersey JH: Bone marrow transplantation across major histocompatibility barriers in mice. V. Protection of mice from lethal GVHD by pretreatment of donor cells with monoclonal anti-thy-1.2 coupled to the toxin lectin ricin. J Exp Med 155:949–954, 1982

    Google Scholar 

  7. Soderling CCB, Song CW, Blazar BR, Vallera DA: A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell depleted murine bone marrow transplants J Immunol 135(2):941–946, 1985

    Google Scholar 

  8. Trigg ME, Billing R, Sondel P,et al. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Cancer Treat Rep 69:377–386, 1985

    Google Scholar 

  9. Mitsugasu RT, Champlin RE, Gale RP,et al Treatment of donor bone marrow with monoclonal anti T cell antibody and complement for the prevention of graft versus host disease. A prospective, randomized, double blind trial. Am Intern Med 105:20–26, 1986

    Google Scholar 

  10. Herve P, Cahn JY, Flesch M: Successful graft versus host disease prevention without graft failure in 32 HLA identical allogeneic bone marrow transplantation with marrow depleted of T cells by monoclonal antibodies and complement. Blood 69:388–393, 1987

    Google Scholar 

  11. Maranchini D, Gluckman E, Blaise D,et al Impact of T cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukemias. Lancet 2:175–177, 1987

    Google Scholar 

  12. Martin PJ, Hansen JA, Buckner CD,et al. Effects of in vitro depletion of T cells in HLA identical marrow grafts. Blood 66(3):664–672, 1985

    Google Scholar 

  13. Prentice HG, Blacklock HA, Janossy G,et al. Depletion of T lymphocytes in donor marrow prevents significant graft versus host disease in matched allogeneic leukemic marrow recipients. Lancet 1:472–476, 1984

    Google Scholar 

  14. Waldmann H, Polliak A, Hale G,et al. Elimination of graft versus host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat and anti-human lymphocyte antibody (Campath-1). Lancet 2:483–486, 1984

    Google Scholar 

  15. Ash RC, Jansen J, Kersey JH,et al. Normal human pluripotential and commited hematopoietic progenitors do not express the p24 antigen detected by monoclonal antibody BA-2: Implications for immunotherapy of lymphocytic leukemia. Blood 60(6):1310–1316, 1982

    Google Scholar 

  16. LeBien TW, Ash RC, Zanjani ED, Kersey JH: In vitro cytodestruction of leukemic cells in human bone marrow using a cocktail of monoclonal antibodies. 1.In Modern Trends in Human Leukemia, New York, Springer-Verlag, 1983, pp 112–116

    Google Scholar 

  17. Nadler LM, Takvorian T, Botnick L,et al. Anti-B1 monoclonal antibody and complement treatment in autologous bone marrow transplantation from relapsed B-cell non-Hodgkin's lymphoma. Lancet 2:427–430, 1984

    Google Scholar 

  18. Jansen J, Ash RC, Zanjani ED,et al. Monoclonal antibody BA-1 does not bind to hematopoietic precursor cells. Blood 59(5):1029–1035, 1982

    Google Scholar 

  19. Bast RC Jr, DeFabritiis P, Lipton, J,et al. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 45(2):499–503, 1985

    Google Scholar 

  20. Bradstock KF, Favaloro EJ, Kabral A,et al. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia. Pathology 18(2):197–205, 1986

    Google Scholar 

  21. LeBien TW, Anderson JM, Vallera DA, Uckun FM: Increased efficacy in selective elimination of leukemic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosphamide (ASTA Z 7557). Leukemia Res 10:139–143, 1985

    Google Scholar 

  22. Ramsay N, LeBien T, Nesbit M,et al. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow tested with monoclonal antibodies BA-1, BA-2, BA-3 plus complement. Blood 66(3):508–513, 1985

    Google Scholar 

  23. Ito T, Ishikawa Y, Noda M, Fujii R: Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: Analyses for two cases of failure. Jap J Clin Oncol 17(1):63–69, 1987

    Google Scholar 

  24. Uckun FM, Gajl-Peczalska KJ, Kersey JH, Houston LL, Vallera DA: Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia. J Exp Med 163(2):347–368, 1986

    Google Scholar 

  25. Ramakrishnan S, Uckun FM, Houston LL: Anti-T cell immunotoxins containing pokeweed anti-viral protein: Potential purging agents for human autologous bone marrow transplantation. J Immunol 135(5):3616–3622, 1985

    Google Scholar 

  26. Uckun FM, Gajl-Peczalska K, Meyers DE,et al. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: Efficacy of ex vivo treatment with immunotoxins and 4-HC against fresh leukemic marrow progenitor cells. Blood 69(1):361–366, 1987

    Google Scholar 

  27. Kvalheim G, Fodstad O, Pihl A,et al. Elimination of B-lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res 47(3):846–851, 1987

    Google Scholar 

  28. Favrot MC, Philip I, Philip T,et al. Bone marrow purging procedure in Burkitt lymphoma with monoclonal antibodies and complement: Quantification by a liquid cell culture monitoring system. Br J Haematol 64(1):161–168, 1986

    Google Scholar 

  29. Sabbath KD, Ball ED, Larcom P, Davis RB, Griffin JD: Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest 75(2):746–753, 1985

    Google Scholar 

  30. Lowenberg B, Bauman JGL: Further results in understanding the subpopulation structure of AML: Clonogenic cells and their progeny identified by differentiation markers. Blood 66(6):1225–1232, 1985

    Google Scholar 

  31. Ball ED, Mills LE, Coughlin CT, Beck JR, Cornwell GG: Autologous bone marrow transplantation in acute myelogenous leukemia: In vitro treatment with myeloid cell-specific monoclonal antibodies. Blood 68(6):1311–1315, 1986

    Google Scholar 

  32. Ferrero DD, De Fabritiis P, Amodori S,et al. Autologous bone marrow transplantation in acute myeloid leukemia with an anti-lacto-N-fucopentaose III antibody and rabbit complement. Leukemia Res 11(3):265–272, 1987

    Google Scholar 

  33. Uckun FM, LeBien TW, Gajl-Peczalska KJ,et al. Ex vivo marrow purging in autologous bone marrow transplantation for acute lymphoblastic leukemia: Use of novel colony assays to test the anti-leukemic efficacy of various strategies.In Progress in Bone Marrow Transplantation, UCLA Symposium, New York, Alan R. Liss, 1987, Vol 53, pp 759–772

    Google Scholar 

  34. Dinsmore R, Kirkpatrick D, Flomenberg N,et al. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood 62:381–388, 1983

    Google Scholar 

  35. Woods WG, Nesbit ME, Ramsay NKC,et al. Intensive therapy followed by bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Determination of prognostic factors. Blood 61:1182–1189, 1983

    Google Scholar 

  36. Sanders JE, Flournoy N, Thomas ED,et al. Marrow transplant experience in children with acute lymphoblastic leukemia: An analysis for factors associated with survival, relapse, and graft-versus-host disease. Med Pediat Oncol 13:165–172, 1985

    Google Scholar 

  37. Hansen JA, Clift RA, Beatty PG,et al. Marrow transplantation from donors other than HLA genotypically identical to siblings.In Recent Advances in Bone Marrow Transplantation, RP Gale, (ed). New York, Alan R. Liss, 1983, pp 739–756

    Google Scholar 

  38. Gingrich RD, Howe CWS, Goeken NE,et al. The use of partially matched, unrelated donors in clinical bone marrow transplantation. Transplantation 39:526–532, 1985

    Google Scholar 

  39. Ritz J, Sallan SE, Bast RC,et al. Autologous bone marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 2:60–63, 1982

    Google Scholar 

  40. Sallan S: Personal communication

  41. Kersey JH, Weisdorf D, Nesbit ME,et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukemia. N Engl J Med 317(8):461–467, 1987

    Google Scholar 

  42. Sanders JE, Thomas ED, Buckner CD,et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: An update. Blood 66:460–462, 1985

    Google Scholar 

  43. Dinsmore R, Kirkpatrick D, Flomenberg N,et al. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood 63:649–656, 1984

    Google Scholar 

  44. Bostrom B, Brunning R, McGlave P,et al. Factors predicting relapse following bone marrow transplantation (BMT) for acute nonlymphocytic leukemia (ANLL). Blood 65:1191–1196, 1985

    Google Scholar 

  45. Burnett AK, Tansey P, Watkins,et al. Transplantation of unpurged autologous bone marrow in adult myeloid leukemia in first remission. Lancet 2:1068–1070, 1984

    Google Scholar 

  46. Stewart P, Buckner CD, Bensinger W,et al. Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. Exp Hematol 13:367–272, 1985

    Google Scholar 

  47. Yeager AM, Kaizer H, Santos GW,et al. Autologous bone marrow transplantation in patients with acute non-lymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141–147, 1986

    Google Scholar 

  48. Santos GW, Tutschka PJ, Brookmeyer R,et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309:1347–1353, 1983

    Google Scholar 

  49. Spitzer G, Vellekoop L, Zander A,et al. Autologous bone marrow transplantation in leukemia and lymphoma. J Exp Clin Cancer Res 3:317–332, 1983

    Google Scholar 

  50. Hurd D, LeBien T, Petersen B,et al. Intensive therapy and autologous bone marrow support for the treatment of refractory non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 5:193, 1986 (abstr)

    Google Scholar 

  51. Takvarian T, Canellos GP, Ritz J,et al. Prolonged diseasefree survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 316:1499–1505, 1987

    Google Scholar 

  52. Shapiro RS, Pietryga D, Blazar BR,et al. B cell lymphoproliferative disorders following bone marrow transplantation.In Progress in Bone Marrow Transplantation, UCLA Symposium. New York, Alan R. Liss, 1987, Vol 53, pp 647–658

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplantation Program and Departments of Pediatrics and Laboratory Medicine and Pathology, University of Minnesota, 55445, Minneapolis, Minnesota

    Norma K. C. Ramsay & John H. Kersey

Authors
  1. Norma K. C. Ramsay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John H. Kersey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramsay, N.K.C., Kersey, J.H. Bone marrow purging using monoclonal antibodies. J Clin Immunol 8, 81–88 (1988). https://doi.org/10.1007/BF00917894

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917894

Key words

Search

Navigation